← Back to Search

Computerized Therapy for Depression

N/A
Waitlist Available
Led By Simon Hatcher, MD.
Research Sponsored by University of Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 and 12 weeks
Awards & highlights

Study Summary

Depression is common and disabling but access to specialist treatment is often delayed with waiting lists of up to a year not uncommon. Also treatment is frequently limited to drug therapies because of long waiting lists to see psychological therapists face to face despite recommendations by NICE (The National Institute for Health and Clinical Excellence) and others about the importance of non-drug therapies. One way to address this problem is to use computerized e-therapies which deliver structured cognitive behavioral treatment where the therapy can be accessed in a location and at a time that is convenient for patients and where there is no waiting list. Previous randomized controlled trials of e-therapies for depression have mainly been in people recruited through the internet or in clinical populations with mild disorders where many participants do not complete the on-line course. Despite this there is some evidence that clinician-assisted computerized cognitive behavior therapy can result in significant improvements in depression with reduced demands on clinician time. To date there have been no trials of clinician assisted e-therapy in secondary care. Therefore the aim of this clinical trial is to answer the question "In patients on the waiting list for the mood program does a computerized therapy with an e-therapy coach compared to written information about depression and the availability of computerized treatments result in better outcomes, quicker improvements and the use of fewer resources after 12 weeks". The study will be a randomized controlled trial with health service use and PHQ-9 as the main outcome measures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2, 6 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2, 6 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Scores on PHQ-9 Scale
Secondary outcome measures
Change in Scores on EQ-5D Scale
Change in Scores on SF-12 Scale
Hospital Admission from ICES data
+4 more
Other outcome measures
Demographic Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Computerized TherapyExperimental Treatment1 Intervention
In addition to their usual clinical care they will receive an invitation to use The Journal supported by an e-therapy coach who will provide patients with weekly email or telephone contact. The e-therapy coach will have a guideline script for each lesson of The Journal to reinforce the topic of each lesson, help identify and support patients in their goals and to coach them in goal setting and the techniques of problem solving.
Group II: ControlActive Control1 Intervention
In addition to their usual clinical care will also be given written information about web sites that provide information on depression but will not be specifically directed to The Journal.

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor
208 Previous Clinical Trials
267,046 Total Patients Enrolled
11 Trials studying Depression
1,391 Patients Enrolled for Depression
Simon Hatcher, MD.Principal InvestigatorUniversity of Ottawa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby May 2025